ProKidney (NASDAQ:PROK) Trading Down 0.7% - Time to Sell?Market Beat·Jul 24 at 01:20 AMPROK+4.33%JPM+1.07%
US Micro-Caps and Legacy Equities Navigate 2026 Strategic ShiftsGlobal Report·Jul 22 at 04:18 AMPROK+4.33%FNMA+1.13%
ProKidney Highlights Progress in Pivotal Phase 3 CKD TrialTip Ranks·May 15 at 11:20 AMPROK+4.33%BBH+1.14%
ProKidney | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 226 KEarnings Watch·May 15 at 10:51 AMPROK+4.33%
PROKIDNEY CORP. 1Q 2026: Revenue $0.226M, EPS $(0.14) — 10-Q SummaryTradingView·May 15 at 10:51 AMPROK+4.33%SBIO+2.18%
ProKidney Reports First Quarter 2026 Financial Results and Business Highlights | PROK Stock NewsStockTitan·May 15 at 02:45 AMPROK+4.33%BIB+2.98%
ProKidney | 10-K: FY2025 Revenue Beats Estimate at USD 893 KEarnings Watch·Apr 24 at 05:33 AMPROK+4.33%
ProKidney (NASDAQ:PROK) Trading Down 7.6% - Here's What HappenedMarket Beat·Mar 24 at 02:28 PMLABU+5.03%IBB+1.42%
